A Phase 1b/2 Study of Repeat Radiation, Minocycline, and Bevacizumab in Patients With Recurrent Glioma.

Trial Profile

A Phase 1b/2 Study of Repeat Radiation, Minocycline, and Bevacizumab in Patients With Recurrent Glioma.

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 23 Aug 2016

At a glance

  • Drugs Bevacizumab (Primary) ; Minocycline (Primary)
  • Indications Glioma
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms RAMBO
  • Most Recent Events

    • 16 Aug 2016 Planned End Date changed from 1 Jul 2016 to 1 Aug 2020.
    • 16 Aug 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Aug 2020.
    • 11 Aug 2015 Planned End Date changed from 1 Jul 2015 to 1 Jul 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top